The pharmacokinetics of Norpace.
D000284:Administration, Oral; D000889:Anti-Arrhythmia Agents / Q000097:blood / Q000378:metabolism* / Q000652:urine; D002250:Carbon Radioisotopes; D055598:Chemical Phenomena; D002621:Chemistry; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D002986:Clinical Trials as Topic; D004206:Disopyramide / Q000097:blood / Q000378:metabolism* / Q000652:urine; D005243:Feces / Q000032:analysis; D006207:Half-Life; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D011725:Pyridines / Q000378:metabolism*
D000889:Anti-Arrhythmia Agents; D002250:Carbon Radioisotopes; D011725:Pyridines; D004206:Disopyramide